Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Le Loarer

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Annales De Pathologie|May 18, 2023
[Histoseminar: "When paediatric and adult tumours converge" Case 5]F Le Loarer, A V Decouvelaere
Annales De Dermatologie Et De Venereologie|April 14, 2009
[Severe drug eruption caused by a medication error]F Le Loarer, D Carré-Gislard, S Baricault, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2022
Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancerM Brunet, A Crombé, S Cousin, et al.
European Journal of Radiology|April 25, 2018
Homogeneous myxoid liposarcomas mimicking cysts on MRI: A challenging diagnosisA Crombé, F Le Loarer, N Alberti, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 19, 2020
Pre- or postoperative radiotherapy for soft tissue sarcomasC Llacer-Moscardo, M Terlizzi, S Bonvalot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2017
The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric seriesE Stoeckle, A Michot, L Rigal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
CHK1 inhibition in soft-tissue sarcomas: biological and clinical implicationsA Laroche-Clary, C Lucchesi, C Rey, et al.
ESMO Open|September 13, 2025
Assessing targetable NTRK1/2/3 fusions in mesenchymal tumors via whole-exome RNA sequencingH Vanacker, M Brahmi, D Pissaloux, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC studyA Le Cesne, P Marec-Berard, J-Y Blay, et al.
ESMO Open|February 1, 2021
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomasM Brahmi, T Lesluyes, A Dufresne, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Annales De Pathologie|May 18, 2023
[Histoseminar: "When paediatric and adult tumours converge" Case 5]F Le Loarer, A V Decouvelaere
Annales De Dermatologie Et De Venereologie|April 14, 2009
[Severe drug eruption caused by a medication error]F Le Loarer, D Carré-Gislard, S Baricault, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2022
Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancerM Brunet, A Crombé, S Cousin, et al.
European Journal of Radiology|April 25, 2018
Homogeneous myxoid liposarcomas mimicking cysts on MRI: A challenging diagnosisA Crombé, F Le Loarer, N Alberti, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 19, 2020
Pre- or postoperative radiotherapy for soft tissue sarcomasC Llacer-Moscardo, M Terlizzi, S Bonvalot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2017
The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric seriesE Stoeckle, A Michot, L Rigal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
CHK1 inhibition in soft-tissue sarcomas: biological and clinical implicationsA Laroche-Clary, C Lucchesi, C Rey, et al.
ESMO Open|September 13, 2025
Assessing targetable NTRK1/2/3 fusions in mesenchymal tumors via whole-exome RNA sequencingH Vanacker, M Brahmi, D Pissaloux, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC studyA Le Cesne, P Marec-Berard, J-Y Blay, et al.
ESMO Open|February 1, 2021
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomasM Brahmi, T Lesluyes, A Dufresne, et al.
Pageof 2